Compare · SHOP vs SNCE
SHOP vs SNCE
Side-by-side comparison of Shopify Inc. (SHOP) and Science 37 Holdings Inc. (SNCE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SHOP and SNCE operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- SHOP is the larger of the two at $109.55B, about 118.9x SNCE ($921.1M).
- SHOP has hit the wire 8 times in the past 4 weeks while SNCE has been quiet.
- SHOP has more recent analyst coverage (25 ratings vs 5 for SNCE).
- Company
- Shopify Inc.
- Science 37 Holdings Inc.
- Price
- $113.75+1.57%
- $5.75+0.17%
- Market cap
- $109.55B
- $921.1M
- 1M return
- -0.34%
- -
- 1Y return
- -8.61%
- -
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 8
- 0
- Recent ratings
- 25
- 5
Shopify Inc.
Shopify Inc., a commerce company, provides a commerce platform and services in Canada, the United States, the United Kingdom, Australia, Latin America, and internationally. The company's platform provides merchants to run their business in various sales channels, including web and mobile storefronts, physical retail locations, pop-up shops, social media storefronts, native mobile apps, buy buttons, and marketplaces; and enables to manage products and inventory, process orders and payments, fulfill and ship orders, new buyers and build customer relationships, source products, leverage analytics and reporting, and access financing. It also sells custom themes and apps, and registration of domain names. The company was formerly known as Jaded Pixel Technologies Inc. and changed its name to Shopify Inc. in November 2011. Shopify Inc. was incorporated in 2004 and is headquartered in Ottawa, Canada.
Latest SHOP
- Shopify downgraded by Rothschild & Co Redburn with a new price target
- Shopify upgraded by Jefferies with a new price target
- SEC Form 144 filed by Shopify Inc.
- Shopify upgraded by Stifel with a new price target
- Shopify to Announce Second-Quarter 2026 Financial Results
- BofA Securities resumed coverage on Shopify with a new price target
- Shopify Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 144 filed by Shopify Inc.
- Shopify Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
- Shopify Announces Results of its 2026 Annual Meeting of Shareholders
Latest SNCE
- Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial
- Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research
- Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
- Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation
- Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
- Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
- Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
- Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
- Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance